Lucid Diagnostics Inc. (LUCD) Tops Q1 EPS by 4c

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.06 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Robinhood prices $2B convertible notes offering due 2029
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits